Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Thromboxane receptor ligand
BML-RA103-0001 1 mg 90.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-340-016

Potent, selective thromboxane A2 receptor antagonist. Shows inhibition of human platelet aggregation initiated by arachidonic acid (IC50=12nM) . Ki=7.9 nM for inhibition of [3H]-U-46619 binding to human platelet membranes.

Product Specification

Alternative Name:[1S-[1α,2α(Z),3α,4α]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptanoic acid]
Purity:≥98% (HPLC)
Appearance:White to off-white crystalline powder.
Solubility:Soluble in 100% ethanol, methanol or acetonitrile; also soluble in PBS, pH 7.2, DMSO or dimethyl formamide.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Technical Info/Product Notes:Note: Product is not sterile.
Please mouse over

Product Literature References

Effect of hypoxia in mice mesenteric arteries surrounded by adipose tissue: N. Maenhaut, et al.; Acta Physiol. (Oxf.) 203, 235 (2011), Abstract;
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells: M. Fukunaga, et al.; Am. J. Physiol. 264, C1619 (1993), Abstract;
7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors: M. Naka, et al.; J. Pharmacol. Exp. Ther. 262, 632 (1992), Abstract;
Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes: H. Monshizadegan, et al.; Life Sci. 51, 431 (1992), Abstract;
Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells: J.A. Hunt, et al.; Biochem. Pharmacol. 43, 1747 (1992), Abstract;
Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles: M.L. Ogletree & G.T. Allen; J. Pharmacol. Exp. Ther. 260, 789 (1992), Abstract;
PgH2 analogs as potential antiplatelet derivatives: D. Komiotis, et al.; J. Med. Chem. 35, 3033 (1992), Abstract;
Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548): E.J. Kattelman, et al.; Thromb Res. 41, 471 (1986), Abstract;
Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist: M.L. Ogletree, et al.; J. Pharmacol. Exp. Ther. 234, 435 (1985), Abstract;

Related Literature

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,